Guardion Health Sciences, Inc.

DB:0QTA Stock Report

Market Cap: €6.7m

Guardion Health Sciences Management

Management criteria checks 1/4

Guardion Health Sciences' CEO is Bret Scholtes, appointed in Jan 2021, has a tenure of 2.25 years. total yearly compensation is $1.80M, comprised of 22.2% salary and 77.8% bonuses, including company stock and options. directly owns 0.48% of the company’s shares, worth €32.30K. The average tenure of the management team and the board of directors is 1.8 years and 5.9 years respectively.

Key information

Bret Scholtes

Chief executive officer

US$1.8m

Total compensation

CEO salary percentage22.2%
CEO tenure2.3yrs
CEO ownership0.5%
Management average tenure1.8yrs
Board average tenure5.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bret Scholtes's remuneration changed compared to Guardion Health Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2022n/an/a

-US$21m

Jun 30 2022n/an/a

-US$22m

Mar 31 2022n/an/a

-US$25m

Dec 31 2021US$2mUS$400k

-US$25m

Compensation vs Market: Bret's total compensation ($USD1.80M) is above average for companies of similar size in the German market ($USD418.12K).

Compensation vs Earnings: Insufficient data to compare Bret's compensation with company performance.

CEO

Bret Scholtes (52 yo)

2.3yrs

Tenure

US$1,804,639

Compensation

Mr. Bret D. Scholtes serves as the President, Chief Executive Officer & Director of Guardion Health Sciences, Inc. since January 6, 2021. He served as the Chief Executive Officer and President of Omega Pro...

Leadership Team

NamePositionTenureCompensationOwnership
Robert Weingarten
Independent Chairman & Secretary7.8yrsUS$141.65k0.19%
$ 13.0k
Bret Scholtes
President2.3yrsUS$1.80m0.48%
$ 32.3k
Craig Sheehan
Chief Commercial Officer1.8yrsUS$619.14k0.081%
$ 5.5k
Jeffrey Benjamin
Chief Accounting Officer1.7yrsno datano data

1.8yrs

Average Tenure

54.5yo

Average Age

Experienced Management: 0QTA's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Robert Weingarten
Independent Chairman & Secretary7.8yrsUS$141.65k0.19%
$ 13.0k
Bret Scholtes
President2.3yrsUS$1.80m0.48%
$ 32.3k
Mark Goldstone
Independent Director7.8yrsUS$103.84k0.14%
$ 9.6k
William Trattler
Member of Medical Advisory Boardno datano datano data
John Hovanesian
Member of Medical Advisory Boardno datano datano data
Donald Gagliano
Independent Director4yrsUS$45.77k0.045%
$ 3.0k
Richard Bone
Member of Science Advisory Boardno datano datano data
John Landrum
Member of Science Advisory Boardno datano datano data
Mark McCarty
Member of Science Advisory Boardno datano datano data
James Davies
Member of Medical Advisory Boardno datano datano data
Joseph Andrews
Member of Medical Advisory Boardno datano datano data
John Wanebo
Member of Medical Advisory Boardno datano datano data

5.9yrs

Average Tenure

63.5yo

Average Age

Experienced Board: 0QTA's board of directors are considered experienced (5.9 years average tenure).